PAVmed Inc.

SecurityPAVM / PAVmed Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership75 shares
Latest Disclosed Value $ 760
UBS Group AG reports 99.97% decrease in ownership of PAVM / PAVmed Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 75 shares of PAVmed Inc. (US:PAVM) valued at $761 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 219,813 shares of PAVmed Inc.. This represents a change in shares of -99.97% during the quarter. The current value of the position is $424 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F PAVMED COM 70387R502 75 -219,738 -99.97 1 -100.00 0.0000
2023-11-09 2023-09-30 13F PAVMED COM 70387R106 1,200 0 0.00 0 0.0000
2023-08-11 2023-06-30 13F PAVMED COM 70387R106 1,200 -21,331 -94.67 0 -100.00 0.0000
2023-05-12 2023-03-31 13F PAVMED COM 70387R106 22,531 10,844 92.79 8 60.00 0.0000
2023-02-08 2022-12-31 13F PAVMED COM 70387R106 11,687 -29,513 -71.63 6 -85.71 0.0000
2022-11-10 2022-09-30 13F PAVMED COM 70387R106 41,200 36,507 777.90 35 775.00 0.0000
2022-08-10 2022-06-30 13F PAVMED COM 70387R106 4,693 -13,432 -74.11 4 -84.00 0.0000
2022-05-16 2022-03-31 13F PAVMED COM 70387R106 18,125 15,927 724.61 25 0.0000
2022-02-14 2021-12-31 13F PAVMED *W EXP 01/29/202 70387R114 2,198 941 74.86 0 -100.00
2022-02-14 2021-12-31 13F PAVMED COM 70387R106 20,335 50
2021-11-15 2021-09-30 13F PAVMED *W EXP 01/29/202 70387R114 1,257 -309 -19.73 5 66.67 0.0000
2021-11-15 2021-09-30 13F PAVMED COM 70387R106 16,969 145
2021-08-13 2021-06-30 13F PAVMED *W EXP 01/29/202 70387R114 1,566 264 20.28 3 50.00 0.0000
2021-05-12 2021-03-31 13F PAVMED *W EXP 01/29/202 70387R114 1,302 631 94.04 2 0.0000
2021-05-12 2021-03-31 13F PAVMED COM 70387R106 44,467 37,621 197 0.0001
2021-02-11 2020-12-31 13F PAVMED *W EXP 01/29/202 70387R114 671 -29 -4.14 0 -100.00
2021-02-11 2020-12-31 13F PAVMED COM 70387R106 6,846 6,485 15 0.0000
2020-11-12 2020-09-30 13F PAVMED *W EXP 01/29/202 70387R114 700 0 0.00 1 0.00 0.0000
2020-11-12 2020-09-30 13F PAVMED COM 70387R106 361 -11,161 1 0.0000
2020-07-31 2020-06-30 13F PAVMED *W EXP 01/29/202 70387R114 700 -818 -53.89 1 0.00 0.0000
2020-07-31 2020-06-30 13F PAVMED COM 70387R106 11,522 10,004 24 0.0000
2020-05-01 2020-03-31 13F PAVMED *W EXP 01/29/202 70387R114 1,518 -17,762 -92.13 1 -95.65 0.0000
2020-02-14 2019-12-31 13F PAVMED COM 70387R106 19,280 17,194 824.26 23 1,050.00 0.0000
2019-08-14 2019-06-30 13F PAVMED COM 70387R106 2,086 -2,893 -58.10 2 -66.67 0.0000
2018-11-14 2018-09-30 13F PAVMED COM 70387R106 4,979 3,773 312.85 6 500.00 0.0000
2018-08-14 2018-06-30 13F PAVMED COM 70387R106 1,206 406 50.75 1 0.0000
2018-05-15 2018-03-31 13F PAVMED *W EXP 01/29/202 70387R114 800 -3,149 -79.74 0 -100.00
2018-05-15 2018-03-31 13F PAVMED COM 70387R106 9,834 5,885 16 0.0000
2018-02-14 2017-12-31 13F PAVMED *W EXP 01/29/202 70387R114 3,949 3,949 -59.84 2 -87.50 0.0000
2017-11-14 2017-09-30 13F PAVMED *W EXP 01/29/202 70387R114 0 -30 -100.00 0 -100.00 0.0000
2017-11-14 2017-06-30 13F/A-1 PAVMED *W EXP 01/29/202 70387R114 30 0 0.00 0 -100.00 0.0000
2017-08-14 2017-06-30 13F PAVMED *W EXP 01/29/202 70387R114 30 0
2017-11-14 2017-03-31 13F/A-1 PAVMED *W EXP 01/29/202 70387R114 30 0 0.00 0 0.0000
2017-11-14 2017-03-31 13F/A-1 PAVMED COM 70387R106 391 361 2 0.0000
2017-05-12 2017-03-31 13F PAVMED *W EXP 01/29/202 70387R114 30 0 0
2017-05-12 2017-03-31 13F PAVMED COM 70387R106 391 361 2
2017-02-14 2016-12-31 13F PAVMED *W EXP 01/29/202 70387R114 30 -30 -50.00 0 0.0000
2016-11-14 2016-09-30 13F PAVMED *W EXP 01/29/202 70387R114 60 60 0 0.0000
2016-11-14 2016-09-30 13F PAVMED COM 70387R106 365 365 4 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.